CNSP CNS Pharmaceuticals, Inc. - Common Stock
$4,90
Prix · Mai 20, 2026
Données fondamentales au Mai 14, 2026
Fourchette 52 semaines
$2–$17
20% of range
Note des analystes
BUY
8 analysts
Objectif de cours
$10
+104% upside
P/E (TTM)
-0.1
ROE
—
Marge nette
—
CNSP Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$4.90
Capitalisation Boursière
—
P/E (TTM)
-0.1
BPA (TTM)
$-35.75
Revenus (TTM)
—
Rendement div.
—
ROE
—
Dette/Capitaux propres
—
Fourchette 52 semaines
$2 – $17
CNSP Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
BPA
$-35.75
2021-12-31
→
2025-12-31
Flux de trésorerie libre
—
2019-12-31
→
2023-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
CNSP
Médiane des pairs
P/E (TTM)
-0.1
42.1
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
CNSP
Médiane des pairs
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
CNSP
Médiane des pairs
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
CNSP
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
CNSP
Médiane des pairs
CNSP Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
8 analystes
- Achat fort 2 25,0%
- Achat 5 62,5%
- Conserver 1 12,5%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
1 analystes · 2026-05-19
Bas
$10.00
Haut
$10.00
Objectif médian
$10.00
+104,1%
Objectif moyen
$10.00
+104,1%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-13.9%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-7.30 | $-5.48 | -1.8% |
| 31 décembre 2025 | $-10.15 | $-5.19 | -5.0% |
| 30 septembre 2025 | $-5.76 | $-7.24 | 1.5% |
| 30 juin 2025 | $-6.42 | $-9.79 | 3.4% |
| 31 décembre 2024 | $-111.00 | $-118.24 | 7.2% |
| 30 septembre 2024 | $-150.00 | $-61.20 | -88.8% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CNSP | — | -0.1 | — | — | — | — |
| PCSA | — | -0.3 | — | — | — | — |
| RVPH | $2M | — | — | — | -485.2% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $10M | $9M | $14M | $9M | $10M | $5M | $2M | $21.3K | |
| SG&A Expense | $6M | $6M | $5M | $6M | $5M | $4M | $2M | $860.5K | |
| Operating Expenses | $16M | $15M | $19M | $15M | $14M | $9M | $4M | $881.8K | |
| Operating Income | $-16M | $-15M | $-19M | $-15M | $-14M | $-9M | $-4M | $-881.8K | |
| Interest Expense | · | · | $13.8K | $7.0K | $9.3K | $3.3K | $26.2K | $28.6K | |
| Interest Income | · | · | $27.7K | $0 | · | · | · | · | |
| Other Non-op | $136.0K | $44.1K | $13.9K | $-7.0K | $-9.3K | $-3.3K | $-44.2K | $-7M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-16M | $-15M | $-19M | $-15M | $-14M | $-9M | $-4M | $-7M | |
| EPS (Basic) | $-35.75 | $-466.89 | $-12509.11 | $-11.22 | $-16.50 | · | · | · | |
| EPS (Diluted) | $-35.75 | $-466.89 | $-12509.11 | $-11.22 | $-16.50 | · | · | · | |
| Shares (Basic) | 443,369 | 31,823 | 1,507 | 1,361,737 | 878,443 | · | · | · | |
| Shares (Diluted) | 443,369 | 31,823 | 1,507 | 1,361,737 | 878,443 | · | · | · | |
| EBITDA | · | · | $-19M | · | · | · | $-4M | · |
Bilan 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $6M | $548.7K | $10M | $5M | $14M | $7M | $282.7K | |
| Prepaid Expense | $856.3K | $1M | $839.6K | $3M | $2M | $1M | $652.6K | $33.0K | |
| Current Assets | $8M | $9M | $2M | $13M | $7M | $15M | $8M | $588.1K | |
| PP&E (Net) | $17.7K | $6.0K | $4.9K | $5.7K | $16.1K | $23.4K | $18.2K | $0 | |
| Total Assets | $9M | $9M | $2M | $13M | $9M | $16M | $8M | $683.3K | |
| Accounts Payable | $4M | $2M | $6M | $5M | $2M | $946.3K | $243.7K | $128.1K | |
| Accrued Liabilities | · | · | · | $828.4K | $224.9K | $519.8K | $21.5K | $23.6K | |
| Short-term Debt | $328.6K | $326.1K | $300.8K | $410.0K | · | $482.4K | $0 | $35.0K | |
| Current Liabilities | $4M | $3M | $6M | $5M | $3M | $2M | $311.0K | $1M | |
| Total Liabilities | $4M | $3M | $6M | $5M | $3M | $2M | $311.0K | $1M | |
| Total Debt | · | · | $300.8K | · | · | · | $0 | · | |
| Common Stock | $633 | $118 | $2 | $1.6K | $949 | $23.9K | $16.4K | $12.7K | |
| Paid-in Capital | $105M | $91M | $65M | $59M | $42M | $35M | $19M | $7M | |
| Retained Earnings | $-100M | $-84M | $-70M | $-51M | $-35M | $-21M | $-11M | $-8M | |
| Stockholders' Equity | $5M | $6M | $-4M | $8M | $6M | $14M | $8M | $-549.3K | |
| Liabilities + Equity | $9M | $9M | $2M | $13M | $9M | $16M | $8M | $683.3K | |
| Shares Outstanding | 632,516 | 117,796 | 2,486 | 1,617,325 | 949,052 | 23,856,151 | 16,450,234 | 16,450,234 |
Flux de trésorerie 9
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $187.7K | $839.0K | $1M | $1M | $2M | $1M | $477.1K | $110.2K | |
| Operating Cash Flow | $-14M | $-17M | $-14M | $-11M | $-14M | $-7M | $-4M | $-716.4K | |
| CapEx | $18.2K | $4.2K | $3.9K | $4.4K | $5.7K | $17.9K | $20.1K | $0 | |
| Investing Cash Flow | $-18.2K | $-4.2K | $-3.9K | $-4.4K | $-5.7K | $-17.9K | $-20.1K | $0 | |
| Stock Issued | $14M | $23M | $2M | $16M | $5M | · | $10M | $390.5K | |
| Net Stock Activity | · | · | $2M | · | · | · | $10M | · | |
| Financing Cash Flow | $15M | $23M | $5M | $16M | $5M | $14M | $10M | $1M | |
| Taxes Paid | · | · | · | · | $0 | $0 | · | · | |
| Free Cash Flow | · | · | $-14M | · | · | · | $-4M | · |
Rentabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | · | · | -255.5% | · | · | · | -90.2% | · | |
| ROE | · | · | 610.8% | · | · | · | -102.0% | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 0.3 | · | · | · | 25.4 | · | |
| Quick Ratio | · | · | 0.1 | · | · | · | 23.3 | · | |
| Debt / Equity | · | · | -0.1 | · | · | · | 0.0 | · | |
| Interest Coverage | · | · | -1366.5 | · | · | · | -146.6 | · |
Valorisation (TTM) 11
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-16M | $-15M | $-19M | $-15M | $-14M | $-9M | $-4M | · | |
| Market Cap | · | · | $236.78B | · | · | · | $58.48T | · | |
| Enterprise Value | · | · | $236.78B | · | · | · | $58.48T | · | |
| P/E | -0.1 | -0.2 | -3.0 | -6417.1 | -38290.9 | · | · | · | |
| P/B | · | · | -53422.8 | · | · | · | 7693724.1 | · | |
| P / Tangible Book | 0.7 | 16.5 | · | 14318.1 | 2862867.4 | 2740005.6 | · | · | |
| P / Cash Flow | · | · | -16745.1 | · | · | · | -16457307.6 | · | |
| P / FCF | · | · | -16740.5 | · | · | · | -16364649.9 | · | |
| EV / EBITDA | · | · | -12551.0 | · | · | · | -15257220.3 | · | |
| EV / FCF | · | · | -16740.5 | · | · | · | -16364647.8 | · | |
| Earnings Yield | -681.0% | -648.5% | -32.8% | -0.02% | 0.00% | · | · | · |
Compte de résultat 13
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $4M | $3M | $2M | $1M | $3M | $1M | $4M | $1M | $2M | $4M | $3M | $3M | $4M | $3M | $2M | $2M | |
| SG&A Expense | $1M | $3M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | |
| Operating Expenses | $5M | $6M | $3M | $2M | $4M | $3M | $6M | $3M | $4M | $5M | $5M | $4M | $5M | $5M | $3M | $4M | |
| Operating Income | $-5M | $-6M | $-3M | $-2M | $-4M | $-3M | $-6M | $-3M | $-4M | $-5M | $-5M | $-4M | $-5M | $-5M | $-3M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6.6K | · | $1.8K | $3.6K | $5.4K | $2.3K | $538 | $1.6K | |
| Interest Income | · | · | · | · | · | · | · | · | $6.7K | · | $12.9K | $7.8K | $0 | $0 | $0 | $0 | |
| Other Non-op | $38.2K | $30.3K | $34.9K | $34.4K | $36.3K | $23.7K | $23.0K | $-2.6K | $106 | $4.1K | $11.0K | $4.2K | $-5.4K | $-2.3K | $-538 | $-1.6K | |
| Net Income | $-5M | $-6M | $-3M | $-2M | $-4M | $-3M | $-6M | $-3M | $-4M | $-5M | $-5M | $-4M | $-5M | $-5M | $-3M | $-4M | |
| EPS (Basic) | $-7.30 | $-21.99 | $-5.76 | $-6.42 | $-18.93 | $4755.99 | $-153.20 | $-4049.20 | $-1020.48 | $-12400.52 | $-54.14 | $-51.86 | $-2.59 | $-3.55 | $-2.56 | $-2.67 | |
| EPS (Diluted) | $-7.30 | $-21.99 | $-5.76 | $-6.42 | $-18.93 | $4755.99 | $-153.20 | $-4049.20 | $-1020.48 | $-12400.52 | $-54.14 | $-51.86 | $-2.59 | $-3.55 | $-2.56 | $-2.67 | |
| Shares (Basic) | 676,172 | -3,212,262 | 558,868 | 370,127 | 227,220 | -8,869 | 36,593 | 625 | 3,474 | -2,066,076 | 83,542 | 77,547 | 1,906,494 | -2,600,709 | 1,334,417 | 1,334,417 | |
| Shares (Diluted) | 676,172 | -3,212,262 | 558,868 | 370,127 | 227,220 | -8,869 | 36,593 | 625 | 3,474 | -2,066,076 | 83,542 | 77,547 | 1,906,494 | -2,600,709 | 1,334,417 | 1,334,417 | |
| EBITDA | $-5M | · | $-3M | $-2M | $-4M | · | $-6M | $-3M | $-4M | · | $-5M | $-4M | $-5M | · | $-3M | $-4M |
Bilan 17
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $7M | $10M | $12M | $13M | $6M | $7M | $1M | $815.2K | $548.7K | $909.5K | $4M | $5M | $10M | $7M | $9M | |
| Prepaid Expense | $1M | $856.3K | $1M | $2M | $653.8K | $1M | $388.0K | $637.1K | $786.0K | $839.6K | $1M | $2M | $2M | $3M | $2M | $2M | |
| Current Assets | $4M | $8M | $11M | $14M | $14M | $9M | $7M | $2M | $2M | $2M | $2M | $6M | $7M | $13M | $9M | $11M | |
| PP&E (Net) | $22.0K | $17.7K | $3.1K | $3.8K | $4.9K | $6.0K | $2.8K | $3.6K | $4.3K | $4.9K | $3.5K | $3.4K | $4.4K | $5.7K | $8.5K | $11.0K | |
| Total Assets | $5M | $9M | $12M | $15M | $14M | $9M | $7M | $2M | $2M | $2M | $2M | $6M | $7M | $13M | $10M | $12M | |
| Accounts Payable | $4M | $4M | $2M | $1M | $3M | $2M | $4M | $7M | $6M | $6M | $4M | $4M | $3M | $5M | $1M | $490.9K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $260.1K | $853.2K | · | $200.0K | $276.6K | |
| Short-term Debt | $232.4K | $328.6K | $30.8K | $121.8K | $210.7K | $326.1K | $31.2K | $123.2K | $213.1K | $300.8K | · | · | · | $410.0K | · | · | |
| Current Liabilities | $5M | $4M | $2M | $1M | $3M | $3M | $4M | $7M | $6M | $6M | $4M | $4M | $4M | $5M | $1M | $923.9K | |
| Total Liabilities | $5M | $4M | $2M | $1M | $3M | $3M | $4M | $7M | $6M | $6M | $4M | $4M | $4M | $5M | $1M | $923.9K | |
| Total Debt | $232.4K | · | $30.8K | $121.8K | $210.7K | · | $31.2K | $123.2K | $213.1K | · | · | · | · | · | · | · | |
| Common Stock | $811 | $633 | $574 | $504 | $2.9K | $118 | $33.4K | $1.4K | $10.7K | $2 | $4.2K | $4.1K | $2.2K | $1.6K | $40.0K | $40.0K | |
| Paid-in Capital | $105M | $105M | $104M | $104M | $100M | $91M | $85M | $71M | $69M | $65M | $62M | $62M | $59M | $59M | $53M | $53M | |
| Retained Earnings | $-105M | $-100M | $-94M | $-91M | $-89M | $-84M | $-81M | $-76M | $-73M | $-70M | $-64M | $-60M | $-56M | $-51M | $-45M | $-41M | |
| Stockholders' Equity | $70.7K | $5M | $10M | $13M | $11M | $6M | $3M | $-4M | $-4M | $-4M | $-2M | $2M | $3M | $8M | $8M | $12M | |
| Liabilities + Equity | $5M | $9M | $12M | $15M | $14M | $9M | $7M | $2M | $2M | $2M | $2M | $6M | $7M | $13M | $10M | $12M | |
| Shares Outstanding | 811,449 | 632,516 | 574,580 | 504,413 | 2,944,381 | 117,796 | 33,446,403 | 1,443,274 | 10,668,932 | 2,486 | 4,207,068 | 4,140,960 | 2,226,325 | 1,617,325 | 40,032,481 | 40,032,481 |
Flux de trésorerie 8
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2.6K | $85.1K | $18.5K | $21.8K | $62.4K | $129.9K | $271.8K | $234.3K | $202.9K | $232.7K | $194.8K | $289.7K | $290.3K | $289.7K | $289.7K | $286.8K | |
| Operating Cash Flow | $-5M | $-3M | $-2M | $-5M | $-3M | $-5M | $-7M | $-2M | $-3M | $-3M | $-3M | $-3M | $-5M | $-2M | $-2M | $-3M | |
| CapEx | $6.2K | · | · | · | $0 | $4.2K | · | · | · | $2.2K | $1.7K | · | · | $-1 | $1.5K | $2.9K | |
| Investing Cash Flow | $-6.2K | · | · | · | $0 | $-4.2K | · | · | · | $-2.2K | $-1.7K | · | · | $1 | $-1.5K | $-2.9K | |
| Stock Issued | · | $501.7K | $0 | · | · | $5M | $12M | $2M | $4M | $215.6K | $132.9K | $2M | $0 | $5M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $4M | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $404.7K | $406.9K | $-91.6K | $4M | $10M | $5M | $12M | $2M | $3M | $2M | $8.4K | $3M | $-120.3K | $5M | $-117.1K | $-116.2K | |
| Free Cash Flow | $-5M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Rentabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -53.7% | · | -33.4% | -28.0% | -55.8% | · | -115.1% | -56.7% | -78.1% | · | -75.6% | -42.6% | -42.4% | · | -32.3% | -26.7% | |
| ROE | -89.4% | · | -48.5% | -53.8% | -131.5% | · | -695.7% | 275.2% | 755.2% | · | -136.0% | -57.5% | -53.9% | · | -39.1% | -29.8% |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | · | 5.8 | 10.2 | 4.9 | · | 1.8 | 0.3 | 0.3 | · | 0.5 | 1.5 | 1.8 | · | 7.0 | 12.3 | |
| Quick Ratio | 0.6 | · | 5.0 | 8.8 | 4.7 | · | 1.7 | 0.2 | 0.1 | · | 0.2 | 1.1 | 1.3 | · | 5.6 | 9.7 | |
| Debt / Equity | 3.3 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | -0.0 | -0.0 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -535.1 | · | -2466.7 | -1102.8 | -906.3 | · | -6355.0 | -2212.5 |
Valorisation (TTM) 11
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-15M | · | $-16M | $-15M | $-16M | · | $-16M | $-15M | $-17M | · | $-17M | $-16M | $-15M | · | $-14M | $-14M | |
| Market Cap | $2M | · | $5M | $5M | $48M | · | $2.63B | $1.37B | $115.86B | · | $143.88B | $277.03B | $66.79B | · | $6.45T | $10.09T | |
| Enterprise Value | $-779.2K | · | $-5M | $-7M | $35M | · | $2.62B | $1.37B | $115.86B | · | · | · | · | · | · | · | |
| P/E | -0.1 | · | -0.1 | -0.0 | -0.0 | · | -0.0 | -0.2 | -9.6 | · | -307.7 | -1121.0 | -2924.0 | · | -20627.4 | -46666.7 | |
| P/B | 27.4 | · | 0.5 | 0.4 | 4.4 | · | 784.2 | -318.7 | -26151.4 | · | -82654.9 | 112869.3 | 19127.4 | · | 768349.0 | 875447.9 | |
| P / Tangible Book | 27.4 | · | 0.5 | 0.4 | 4.4 | · | 784.2 | · | · | · | · | 112869.3 | 19127.4 | · | 768349.0 | 875447.9 | |
| P / Cash Flow | -0.4 | · | · | · | -14.8 | · | · | · | -36297.8 | · | · | · | -13843.6 | · | · | · | |
| P / FCF | -0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 0.2 | · | 1.4 | 2.9 | -8.1 | · | -465.8 | -540.7 | -32685.1 | · | · | · | · | · | · | · | |
| EV / FCF | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1607.1% | · | -1855.1% | -42529.3% | -32012.6% | · | -6713.8% | -546.0% | -10.4% | · | -0.33% | -0.09% | -0.03% | · | 0.00% | 0.00% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Résultat net | $-16M | $-15M | $-19M | $-15M | $-14M |
| BPA dilué | $-35.75 | $-466.89 | $-12509.11 | $-11.22 | $-16.50 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | — | — | -0.1 | — | — |
| Ratio de liquidité | — | — | 0.3 | — | — |
| Ratio de liquidité réduite | — | — | 0.1 | — | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | — | — | $-14M | — | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.